Oryon Cell Therapies | RoundOS

Weekly digest by email

Loading companies…

Oryon Cell Therapies | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Mar 23, 2026	Series A	$21M	Byers Capital — Role not disclosedNeuro.VC — Role not disclosed

Investors

Byers CapitalSeries A Neuro.VCSeries A

Coverage

Mar 23, 2026Oryon Cell Therapies · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

TransfyrPhysical AI platform capturing real-world lab science into machine-readable data$25M · Seed

Sources

oryoncelltherapies.com ↗